100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
NURS 663 EXAM 2 (Langford) with complete verified solutions 2025. $13.99   Add to cart

Exam (elaborations)

NURS 663 EXAM 2 (Langford) with complete verified solutions 2025.

 4 views  0 purchase
  • Course
  • NURS663
  • Institution
  • NURS663

NURS 663 EXAM 2 (Langford) with complete verified solutions 2025.

Preview 4 out of 47  pages

  • September 21, 2024
  • 47
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • NURS663
  • NURS663
avatar-seller
GUARANTEEDSUCCESS
NURS 663 EXAM 2 (Langford)
with complete verified
solutions 2025
Anorexia Nervosa
"RID" - answer R: Restriction of intake leading to significantly low
body weight
I: Intense fear of weight gain
D: Disturbance in perception of one's weight or body image


When Anorexia Nervosa is Diagnosed - answer When a person's
weighs at least 15% less than their normal/idea body weight


Anorexia Nervosa
Subtype Restricting Type - answer Extreme diet, fasting, excessive
exercise


Anorexia Nervosa
Subtype Binge/Purge Type - answer Self-induced vomiting, laxative
abuse, diuretic abuse, enemas


(Significantly low body weight/Low BMI)


Differentiating Anorexia Nervosa Binge/Purge Type from Bulimia
Nervosa - answer Anorexia nervosa has significantly low body
weight / low BMI


Anorexia Nervosa

,Severity Based on BMI - answer Mild: > 17
Moderate: 16-16.99
Severe: 15-15.99
Extreme: < 15


Anorexia Nervosa
Treatment - answer - Behavioral, interpersonal, cognitive, and
family therapies
- Assessments both psychological and physical
- Psychological and behavioral interventions are key
- Nutritional interventions are required
Pharmacological interventions have limited role with the exception
of treating co-morbidities (MDD, GAD)


Anorexia Nervosa
Conclusion - answer - Least prevalent, the most obvious due to
obvious low weight
- No FDA medication, treat co-occurring mood disorders (MDD, GAD
with SSRI)


Bulimia Nervosa
"Bulimics Over-Consume Pasteries" - answer B: recurrent Binge
episodes (1x/wk x 3 months)
O: Out of control overeating
C: excessive Concern with body shape/weight
P: Purging or other compensatory behaviors


Bulimia Nervosa
Severity Based on # of Episodes/week - answer Mild: 1-3/wk
Moderate: 4-7/wk

,Severe: 8-13/wk
Extreme: 14+/wk


Bulimia Nervosa
Pharmacological Interventions - answer fluoxetine (Prozac) only
FDA-approved, higher dose used than for MDD


Bulimia Nervosa
Conclusion - answer - Second most-prevalent, easier to hide
- fluoxetine (Prozac) FDA-approved, treat co-occurring disorders if
needed (mood stabilizer for MDD treatment-resistant)


Binge Eating Disorder
"Binge-Eaters Overeat" - answer B: recurrent Binge episodes
(1x/wk x 3 months)
O: Out of control overeating


Plus 3 or more of the following:
1. Eat fast past full
2. Feast when not famished
3. Flushed and flustered and feeling disgusted


Binge-Eating Disorder - answer - A sense of lack of control
overeating during the episode
- Occurring AT LEAST 1x per week for 3 MONTHS
- Associated with marked distress


Binge Episodes are Associated with ≥ 3 of the Following: - answer -
Eating more rapidly than usual
- Eating until feeling uncomfortably full

, - Eating large amounts of food when not feeling physically hungry
- Eating alone because of feeling embarrassed by how much one is
eating
- Feeling disgusted with oneself, depressed or guilty afterwards
(Common for all 5 to be present)


Binge-Eating Disorder
Severity Based on # of Episodes/week - answer Mild: 1-3/wk
Moderate: 4-7/wk
Severe: 8-13/wk
Extreme: 14+/wk


Binge Eating Disorder
Pharmacological Interventions - answer lisdexamfetamine
(Vyvanse): Currently the only FDA approved medication


Topiramate: Causes cognitive dysfunction when dosed for
effectiveness
Anti-obesity agents target appetite and weight, but no the behavior
Naltrexone: "Hit or miss," results
Baclofen: Some evidence it reduces automatic behaviors, it can take
high doses; do not abruptly disrupt due to possible psychosis
Dasotraline: In phase 3 for BED and dual-acting DA and NE reuptake
inhibitor, shows promise, not on the market yet


Binge-Eating Disorder
Conclusion - answer - Most prevalent, often not screened for
- Known as a "shameful secret"
- lisdexamefetamine (Vyvanse) only FDA-approved medication

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller GUARANTEEDSUCCESS. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $13.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

79650 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$13.99
  • (0)
  Add to cart